579.54
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Cor - GuruFocus
United Therapeutics director Mesa Nilda sells $150,139 in stock - Investing.com
Varda Space, United Therapeutics to test lung drugs in orbit - qz.com
United Therapeutics (UTHR) Partners with Varda Space Industries for Innovative Drug Development - GuruFocus
Varda and United Therapeutics Partner to Crystallize Protein in Space for Rare Lung Disease Therapies - geneonline.com
Varda Space, United Therapeutics partner on drug development By Investing.com - Investing.com South Africa
Varda Space, United Therapeutics partner on drug development - Investing.com
Could this be the moment that drug manufacturing takes off in orbit? - Ars Technica
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease - ChartMill
United Therapeutics Corp (UTHR) News, Articles, Events & Latest Updates - Stocktwits
United Therapeutics CFO James Edgemond sells $5.7m in stock By Investing.com - Investing.com Nigeria
United Therapeutics CFO James Edgemond sells $5.7m in stock - Investing.com
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy - Quantisnow
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference - ChartMill
Pharma CEO's Role In Ex-Exec's Contract Permits Deposition - Law360
Hedge Fund and Insider Trading News: Ken Griffin, Scott Bessent, Warren Buffett, CastleKnight Management, Saba Capital, Brevan Howard, TCI Fund Management, Aminex PLC (AEX), United Therapeutics Corp (UTHR), and More - Insider Monkey
United Therapeutics (UTHR) Set to Showcase New Data at American Thoracic Society Conference - GuruFocus
United Therapeutics chairperson & CEO Rothblatt sells $5.5m in stock - Investing.com UK
United Therapeutics CFO Edgemond sells $5.7m in stock By Investing.com - Investing.com Nigeria
United Therapeutics CFO Edgemond sells $5.7m in stock - Investing.com India
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026 - ChartMill
United Therapeutics Corporation (UTHR) Stock Analysis: A 17.28% Upside Potential Beckons Investors - DirectorsTalk Interviews
MNKD stock records biggest single-day gains in over 5 years, breaches a key technical milestone – what’s driving this rally? - MSN
MannKind (MNKD) Is Up 25.4% After Mixed Q1 Results and Expanded United Therapeutics Partnership – What's Changed - Yahoo Finance
UTHR Maintained by RBC Capital -- Price Target Lowered to $701 - GuruFocus
United Therapeutics EVP Paul Mahon sells $4.87m in common stock By Investing.com - Investing.com India
United Therapeutics’ Earnings Call Signals Next Growth Phase - The Globe and Mail
United Therapeutics EVP Paul Mahon sells $4.87m in common stock - Investing.com
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2026 Earnings Call Transcript - Insider Monkey
Transcript: United Therapeutics Q1 2026 Earnings Conference Call - Sahm
UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook - TradingView
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More - 24/7 Wall St.
United Therapeutics reports Q1 EPS $5.82, consensus $6.86 - TipRanks
UTHR Q1 Deep Dive: Pipeline Advances and Product Launches Dominate Outlook - StockStory
United Therapeutics: Q1 Earnings Snapshot - theheraldreview.com
United Therapeutics outlines $4B revenue run rate by end of 2027 as ralinepag and IPF plans advance - msn.com
BTIG reiterates Neutral on United Therapeutics stock after Q1 miss - Investing.com UK
BTIG reiterates Neutral on United Therapeutics stock after Q1 miss By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.47m in stock By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com
United Therapeutics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
MSN Money - MSN
TD Cowen Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $660 - Moomoo
자본화:
|
볼륨(24시간):